Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential intramuscular-to-oral ziprasidone treatment in agitated hospitalized patients with acute schizophrenia exacerbation
ChiCTR-OIC-16007970Phase 4Recruiting
- Sponsor
- Peking University Huilongguan Hospital
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ziprasidone in schizophrenia (2 arms), sponsored by Peking University Huilongguan Hospital. Primary endpoints: PANSS score, BARS score and 1 more. Started Apr 2015; status: recruiting.
02
Drugs
ziprasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ChiCTR-OIC-16007970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIC-16007970.